Solco Health Care is categorized under Blood Related Health Services in Cranbury, NJ and active since 2012.
Solco Health Care was established in 2012, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Ronald N Kaufman at the company’s single location by writing to 2002 Eastpark Boulevard, Cranbury, New Jersey NJ 08512 or by phoning (609) 664-2349. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Solco Health Care |
| Contact Person: | Ronald N Kaufman |
| Address: | 2002 Eastpark Boulevard, Cranbury, New Jersey 08512 |
| Phone Number: | (609) 664-2349 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Related Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6219992 |
| Share This Business: |
Solco Health Care was started in 2012 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Ronald N Kaufman for inquiries that concern Solco Health Care by calling the company number (609) 664-2349, as your correspondence is most welcome. Additionally, the physical location of the single location of Solco Health Care can be found at the coordinates 40.340137,-74.499396 as well as the street address 2002 Eastpark Boulevard in Cranbury, New Jersey 08512.
For its online presence, you may visit Solco Health Care’s website at and engage with its social media outlets through on Twitter and on Facebook.